amfAR Announces 2021 Mathilde Krim Fellowship Recipients

New research fellows harness powerful technologies in support of HIV vaccine and latency studies

• Risks and Potential Benefits of Participating in Cure Research
• New amfAR Grants Target Intersection of HIV and COVID-19
• HIV Study Among Top Ten Breakthroughs of 2020

People Living with HIV Should Be Prioritized for Coronavirus Vaccine

Studies have found increased risk of COVID-related hospitalization and mortality among people living with HIV.

• FDA Approves Long-Acting Injectable to Treat HIV
• amfAR Study Wins Elsevier Atlas Award

Getting PrEP to Key Populations Is Critical to Global Fight Against HIV

amfAR's Greg Millett and TREAT Asia's Dr. Annette Sohn participated in the 2021 Conference on Retroviruses and Opportunistic Infections (CROI), was held virtually.

• ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV
• amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event

amfAR Supports CHC Giving Day #ForHealthEquity

As a proud member of CHC: Creating Healthier Communities, amfAR supports CHC Giving Day #ForHealthEquity, March 11, which is promoting health equity efforts in the nation. The campaign will run for the month of March.

It’s a Sin: AIDS in 1980s London

New HBO Max series "It’s a Sin" is a joyful tribute to lives that burned bright as AIDS ravaged the gay community in 1980s London. The series premiered on Thursday, February 18.

Connections - Episode 4: COVID & HIV – Michael Carter

Michael Carter, of London, recounted his experience of HIV and discussed the COVID pandemic in the UK and his participation in an unblinded Oxford-AstraZeneca vaccine study specifically targeting people with HIV.

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.